Trends in Drug Research III - 1st Edition - ISBN: 9780444507600, 9780080543239

Trends in Drug Research III, Volume 32

1st Edition

Editors: H. van der Goot
eBook ISBN: 9780080543239
Imprint: Elsevier Science
Published Date: 25th January 2002
Page Count: 272
Tax/VAT will be calculated at check-out Price includes VAT (GST)
30% off
30% off
30% off
30% off
30% off
20% off
20% off
30% off
30% off
30% off
30% off
30% off
20% off
20% off
30% off
30% off
30% off
30% off
30% off
20% off
20% off
30% off
30% off
30% off
30% off
30% off
20% off
20% off
155.00
108.50
108.50
108.50
108.50
108.50
124.00
124.00
205.00
143.50
143.50
143.50
143.50
143.50
164.00
164.00
190.00
133.00
133.00
133.00
133.00
133.00
152.00
152.00
125.00
87.50
87.50
87.50
87.50
87.50
100.00
100.00
Unavailable
Price includes VAT (GST)
× DRM-Free

Easy - Download and start reading immediately. There’s no activation process to access eBooks; all eBooks are fully searchable, and enabled for copying, pasting, and printing.

Flexible - Read on multiple operating systems and devices. Easily read eBooks on smart phones, computers, or any eBook readers, including Kindle.

Open - Buy once, receive and download all available eBook formats, including PDF, EPUB, and Mobi (for Kindle).

Institutional Access

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

Preface.

  1. Towards rational design of AMPA receptor ligands: an integrated medicinal, computational, biostructural and molecular pharmacological approach (A. Hogner, et al.).
  2. From heparin to synthetic antithrombotics. The pentasaccharide story and follow up (C.C.A. van Boeckel).
  3. A new future for synthesis? (A. Bruggink).
  4. Directed evolution of enantioselective enzymes as catalysts in the production of chiral pharmaceuticals (M.T. Reetz).
  5. At the interface of organic synthesis and biosynthesis (R. Schoevaart, A.P.G. Kieboom).
  6. What can structure tell us about function in the estrogen receptors? (R.E. Hubbart).
  7. Molecular docking and dynamics simulations in the ligand binding domain of steroid hormone receptors (M. Kouwijzer, J. Mestres).
  8. Peroxisome proliferator-activated receptors and reverse endocrinology (S. Kliewer).
  9. Biomolecular mass spectrometry related to drug research (A.J.R. Heck, C.S. Maier).
  10. Chemical and biological diversity in drug discovery (P. Angeli, G. Gaviraghi).
  11. Muscarine acetylcholine receptor knockout mice: phenotypical analysis and clinical implications (J. Gomeza, et al.).
  12. Changes in expression of the orphan G-protein coupled receptor GPR7 in human painful peripheral neuropathies (P.F. Zaratin, et al.).
  13. Computational methods for the analysis of molecular diversity (V.J. Gillet, P. Willett).
  14. Enhancing drug discovery by acquisition of chemical diversity (D. Langley).
  15. Chemical diversity as a driving force to design and put in practice synthetic strategies leading to combinatorial libraries for lead discovery and lead optimization (P. Seneci).
  16. Beyond G proteins: the role of accessory proteins in G protein-coupled receptor signalling (H. Just, et al.).
  17. Mechanisms of action of antipsychotic drugs: the role of inverse agonism at the D2 dopamine receptor (Ph.G. Strange).
  18. Agonist channeling of &agr;2-adrenoceptor function (K.E.O. Åkerman, et al.).
  19. Antibacterials as wonder drugs and how their effectiveness is being compromised (D. Golemi, et al.).
  20. Pseudomonas aeruginosa quorum sensing: a target for antipathogenic drug discovery (E.P. Greenberg).
  21. Discovery and development of new anti-bacterial drugs (I. Chopra, L. Hesse, A. O'Neill).
  22. Discovery of small molecule insulin mimetics as potential novel antidiabetic agents (B.B. Zhang).
  23. Expression databases for pharmaceutical lead optimisation (L.M. Furness).
  24. New developments in the pharmacology of cannabinoids (R.G. Pertwee). Author index. Subject index.

Description

The tradition of setting new trends in medicinal chemistry continued at the 13th Symposium where topics included chemical and biological diversity, new paradigms in drug action, and new insights in receptor mechanisms. Other topics of great interest discussed, and included in these proceedings, are the discoveries in green chemistry, the interface between organic synthesis and biosynthesis, the growing problem of resistant micro-organisms and the possibilities to identify new, and better, antibiotics. And finally, in recent developments, the discovery of small molecules with insulin sensitizing properties.

Readership

For clinical pharmacologists, pharmaceutics and toxicologists


Details

No. of pages:
272
Language:
English
Copyright:
© Elsevier Science 2002
Published:
Imprint:
Elsevier Science
eBook ISBN:
9780080543239

About the Editors

H. van der Goot Editor

Affiliations and Expertise

Department of Pharmacochemistry, Vrije Universiteit, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands